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WE previously showed that short-course tacrolimus immunosuppression prolongs allograft survival for 
> 100 days in rats. Histopathological examination of long-
surviving allografts revealed severe chronic rejections with 
obliterative arteriopathy, lymphohitiocytic interstitial in-
flammation, patchy interstitial fibrosis, and atrophy of pa- • 
renchymal elements in heart grafts; however, liver grafts 
were intact. 1,2 Passenger leukocytes, normal constituents of 
all whole organs, migrate after transplantation and produce 
micro chimerism, which is suggested to be essential for the 
sustained survival of allografts,3 One of the possible roles of 
donor passenger leukocytes is to regulate alloreactive re-
cipient T cells via activation-induced apoptosis. This study 
analyzed the frequency and nature of migrating donor 
leukocytes and apoptosis after liver and heart transplanta-
tion, 
METHODS 
Brown Norway (BN) recipients underwent heterotopic heart (HTx) 
or orthotopic liver transplantation (OLTx) from Lewis (LEW) 
donors and were sacrificed at various predetermined time points 
(n = 2 to 6 for each time point).4 Recipients were treated with a 
short course oftacrolimus (1.0 mglkg/d) on days 0 to 13,20, and 27. 
Apoptotic cells (TUNEL assay) and mRNA levels for cytokines 
and apoptotic signals (RNase protection assay) were examined in 
recipient spleens and allografts? Donor cells were determined by 
flow cytometry (LEW MHC class I, MAb 163) and immunohisto-
chemistry (LEW MHC class II, MAb L21-6).5 
RESULTS 
Donor MHC class 1+ cells accounted for 4% to 7% of 
splenocytes early after OLTx but were not detected after 
HTx by flow cytometry (Table 1). Donor MHC class II+ 
cells were eminently identified at the periphery of the 
splenic periarterial lymphatic sheath and marginal zone 
with a frequency 10-fold more after OLTx than after HTx. 
Accordingly, splenic BrdU+ cells dramatically increased 
after OLTx, followed by an increase in TUNEL + cells and 
mRNA for apoptotic signals in 14 days. Interestingly, 
however, the upregulation of splenic mRNA for IL-2 and 
gamma-IFN was more prominent after HTx than after 
OLTx. In heart allografts there was an upregulation of 
mRNA for IL-2 and gamma-IFN, with an increase in 
BrdU+ infiltrates. In contrast, liver grafts showed an in-
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Table 1. Development of Chronic Allograft Rejection and Early 
Changes in Cytokine Responses and Frequency of 
Proliferation and Apoptosis in Allografts and 
Recipient Spleens· 
Group POD HTx OLTx 
Chronic allograft rejection 100 +++ 
Spleen 
Donor MHC 11+ (cells/HPF) 317 0.1610.02 10.6/1.7 
Donor MHC 1+ (%) 7 0.0 5.4 
IL-2 (%/GAPDH) 3 2.69 0.00 
IFN-y 3 6.46 2.6 
IL-4 3 2.82 2.93 
IL-10 3 5.00 3.01 
Fas 14 3.4'4 7.41 
FasL 14 2.94 7.36 
Caspase 3 14 10.03 21.90 
BrdU+ (cells/HPF) 3/7 30.1/39.9 94.8/65.5 
TUNEL 14 12.1 25.5 
Graft 
IL-2 (%/GAPDH) 3 1.44 0.17 
IFN-r 3 1.54 0.29 
IL-4 3 0.58 0.83 
IL-10 3 0.62 2.27 
Fas 14 3.76 5.87 
Fas.L 14 1.53 1.36 
Caspase 3 14 8.81 19.21 
BrdU+ (cells/HPF) 7 21.4 6.6 
TUNEL 14 2.6 7.5 
All numbers are the mean of two to six samples. 
Abbreviations: POD, postoperative day; GAPDH. glyceraldehyde-3-phos-
phate dehydrogenase; HPF, high-power field (X400); BrdU, 5-bromo-2'·de· 
oxyuridine; TUNEL, terminal deoxynucleotidyl transferase-mediated biotin-
dUTP nick end labeling. 
crease in TUNEL + cells and an upregulation of mRNA for 
apoptosis. 
DISCUSSION 
Migration of donor MHC class II+ cells after OLTx to 
recipient lymphoid tissues under tacrolimus induced splenic 
From the Thomas E. Starzl Transplantation Institute, Depart-
ments of Surgery and Pathology, University of Pittsburgh, Pitts-
burgh, Pennsylvania, USA. 
Address reprint requests to Dr Okuda, E1505 Biomedical 
Science Tower, 200 Lothrop Street, Pittsburgh, PA 15261. 
0041-1345/01/$-see front matter 
PII S0041-1345(00)02829-3 
271 
., 
, 
272 
proliferation and subsequent apoptosis of splenocytes with-
out a Thl-type cytokine-rich milieu. This resulted in a 
Th2-type cytokine-dominant milieu in liver allografts and 
apoptosis in graft' infiltrates. Donor passenger leukocytes 
expressing MHC class II+ may play an active role in liver 
graft acceptance under tacrolimus treatment. 
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